Bonesupport Holding AB (publ)
Bonesupport Holding AB (publ) (0RQO.L) Financial Performance & Income Statement Overview
Explore the financials of Bonesupport Holding AB (publ) (0RQO.L), including yearly and quarterly data on income, cash flow, and balance sheets.
Bonesupport Holding AB (publ) (0RQO.L) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Bonesupport Holding AB (publ) 0RQO.L financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $283.54M | $257.01M | $237.50M | $219.79M |
| Cost of Revenue | $21.007M | $18.98M | $16.87M | $17.00M |
| Gross Profit | $262.54M | $238.03M | $220.63M | $202.79M |
| Gross Profit Ratio | $0.93 | $0.93 | $0.93 | $0.92 |
| R&D Expenses | $23.81M | $21.84M | $19.68M | $20.32M |
| SG&A Expenses | $129.45M | $131.44M | $153.74M | $152.76M |
| Operating Expenses | $232.89M | $173.81M | $179.67M | $173.08M |
| Total Costs & Expenses | $253.90M | $192.79M | $196.54M | $190.08M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $349000.00 | $209000.00 |
| Depreciation & Amortization | $1.84M | $1.27M | $1.88M | $1.90M |
| EBITDA | $31.47M | $65.48M | $42.84M | $31.62M |
| EBITDA Ratio | $0.11 | $0.25 | $0.18 | $0.14 |
| Operating Income | $29.65M | $64.22M | $40.96M | $29.71M |
| Operating Income Ratio | $0.10 | $0.25 | $0.17 | $0.14 |
| Other Income/Expenses (Net) | -$16.56M | $7.85M | -$349000.00 | -$1.25M |
| Income Before Tax | $13.09M | $72.07M | $40.61M | $28.47M |
| Income Before Tax Ratio | $0.05 | $0.28 | $0.17 | $0.13 |
| Income Tax Expense | $2.66M | $18.16M | $10.04M | $1.04M |
| Net Income | $10.43M | $53.91M | $30.57M | $27.43M |
| Net Income Ratio | $0.04 | $0.21 | $0.13 | $0.12 |
| EPS | $0.16 | $0.82 | $0.46 | $0.42 |
| Diluted EPS | $0.16 | $0.81 | $0.46 | $0.41 |
| Weighted Avg Shares Outstanding | $65.86M | $65.83M | $65.76M | $65.72M |
| Weighted Avg Shares Outstanding (Diluted) | $66.82M | $66.82M | $66.74M | $66.69M |
Financial performance has remained strong, with revenue growing from $219.79M in Q2 2024 to $283.54M in Q1 2025. Gross profit continued to perform well, with margins at 93% in the latest quarter. Operating income reached $29.65M in Q1 2025, holding a steady 10% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $31.47M. Net income dropped to $10.43M, keeping EPS at $0.16. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan